MedTrace Logo

Safety and Performance Evaluation of ReWalk Reciprocating Gait Orthosis (RGO)

NCT01251549 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2016-10-05

No results posted yet for this study

Summary

ReWalk suit developed by Argo Medical Technologies is designed to enable people with lower limb disabilities to carry out routine ambulatory functions (stand, walk etc.); it can be used by people with disabilities such as spinal cord injury, brain injury, stroke, multiple sclerosis, cerebral palsy and other pathologies that produce severe walking impairments.

Conditions

  • Paraplegia
  • Spinal Cord Injuries (SCI)

Interventions

DEVICE

ReWalk - a motorized exoskeleton suit

The subject will wear the ReWalk suit and have training sessions for walking with the device

Sponsors & Collaborators

  • ReWalk Robotics, Inc.

    lead INDUSTRY

Principal Investigators

  • Alberto Esquenazi, MD · Albert Einstein Medical Center, Moss Rehabilitation Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01251549 on ClinicalTrials.gov